Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
about
Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of NepalAssociation of MRC-1 and IL-28B with the treatment outcome of hepatitis C: a case control studyCurrent challenges and the management of chronic hepatitis C in mainland ChinaMeta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients.Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study.Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms.Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.
P2860
Q28547151-1A4E2171-759A-44BC-8871-734F6900AF20Q33903850-F6FC3CF7-CC27-4AB9-B732-17B8AFF5E4F6Q34171127-5BBA548A-08C9-4882-B4D0-9F25EE7C433EQ34539324-BF7BBFAD-CF76-44D4-B656-9CFAB58567C2Q34604371-4A966985-C239-4E37-9CF9-C9C76C00F963Q35023484-87C0B87F-844C-4779-8EB1-D10EBF3CBB5AQ36301391-C8F84051-58F0-4EBE-BAB6-299AA004B8BCQ36317352-18A1AA0E-9078-435E-A6A8-EDBC4BACCA3AQ38445623-B25604B3-14FE-4044-AE41-D8F68B622A08Q38477511-4F9D0C24-9879-46B6-B752-A8089C4D8664Q40706475-0528F82C-DAD8-4FFF-8F8D-D554CE0BD1C6Q41480323-503B7584-D86D-4DC5-A30C-336D95A1CC85Q42259303-77EE046A-AF8A-495E-A536-F6E9B0966D8CQ52594744-2D4C2AD4-B4B6-4DB9-9582-124EBB177FF3
P2860
Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prediction of response to pegy ...... ent hepatitis C virus genotype
@ast
Prediction of response to pegy ...... ent hepatitis C virus genotype
@en
type
label
Prediction of response to pegy ...... ent hepatitis C virus genotype
@ast
Prediction of response to pegy ...... ent hepatitis C virus genotype
@en
prefLabel
Prediction of response to pegy ...... ent hepatitis C virus genotype
@ast
Prediction of response to pegy ...... ent hepatitis C virus genotype
@en
P2093
P2860
P356
P1433
P1476
Prediction of response to pegy ...... ent hepatitis C virus genotype
@en
P2093
Junqiang Xie
Liang Peng
Qingxian Cai
Xiaohong Zhang
Xiaoyan Guo
Zhiliang Gao
Zhixin Zhao
P2860
P356
10.1186/1743-422X-9-123
P577
2012-06-19T00:00:00Z